GILEAD SCIENCES, INC. — Director's Dealing 2018

Mar 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-03-23

Reporting Person: Cogan John Francis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-23	Common Stock	M	5833	$26.615	Acquired	58452	Direct
2018-03-23	Common Stock	S	5833	$75.0193	Disposed	52619	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-23	Non-qualified Stock Option (Right to Buy)	$26.615	M	5833	Disposed	2018-05-08	Common Stock (5833)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Sale prices reported for the transactions reported here range from $74.63 to $75.41. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F3: Options vest quarterly over a period of one year from date of grant.